Double-Positive Anti-Glomerular Basement Membrane (Anti-GBM) and Anti-Neutrophil Cytoplasm Antibody (ANCA)- Associated Glomerulonephritis is a rare disease. The disease is characterized by concurrent presence of Anti-GBM antibodies and ANCA in a patient. The patient usually presents with rapidly progressive glomerulonephritis with or without pulmonary haemorrhage. We report a case of a middle-aged gentleman who presented acute kidney injury with a serum creatinine level of 459umol/L. He was tested positive for both Anti-GBM and ANCA with high titers. He underwent 6 cycles of plasma exchange, pulse IV cyclophosphamide and high dose steroid. During his 6 months outpatient review, a total of 6 doses IV cyclophosphamide has been given and his serum creatinine reduced to 146 umol/L. In conclusion, the use of pulse IV cyclophosphamide over oral form in this subject is empirical and showed marked improvement of renal function.
2. Short, Andrew K., et al. “Anti-Neutrophil Cytoplasm Antibodies and Anti-Glomerular Basement Membrane Antibodies: Two Coexisting Distinct Autoreactivities Detectable in Patients with Rapidly Progressive Glomerulonephritis.” American Journal of Kidney Diseases, vol. 26, no. 3, 1995, pp. 439–445., doi:10.1016/0272-6386(95)90489-1.
3. Olson, Stephen W., et al. “Asymptomatic Autoantibodies Associate with Future Anti-Glomerular Basement Membrane Disease.” Journal of the American Society of Nephrology, vol. 22, no. 10, 2011, pp. 1946–1952., doi:10.1681/asn.2010090928.
4. Mcadoo, Stephen P., and Charles D. Pusey. “Anti-Glomerular Basement Membrane Disease.” Encyclopedia of Medical Immunology, 2014, pp. 50–56., doi:10.1007/978-0-387-84828-0_53
This work is licensed under a Creative Commons Attribution 4.0 International License.